Author: Huang Gloria Goldberg Gary Fields Abbie
Publisher: Informa Healthcare
ISSN: 1473-3404
Source: The Women's Oncology Review, Vol.5, Iss.1, 2005-03, pp. : 3-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Barakat R.R. Almadrones L. Venkatraman E.S. Aghajanian C. Brown C. Shapiro F. Curtin J.P. Spriggs D.
Gynecologic Oncology, Vol. 69, Iss. 1, 1998-04 ,pp. :
Treosulfan as an Effective Second-Line Therapy in Ovarian Cancer
Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. :
Ovarian Cancer--New Insights into Systemic Therapy
By Neijt J.P.
European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. :
Estrogen Replacement Therapy and Risk of Epithelial Ovarian Cancer
By Risch H.A.
Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. :